The past five years have seen remarkable growth in the use of durable, continuous flow left
ventricular assist devices (LVAD) with associated improvements in mortality, quality of life …

Continuous-flow (CF) left ventricular assist devices (LVADs) have become the standard of
care for patients with advanced heart failure refractory to optimal medical therapy. The goal …

Feature Editor's Introduction—Durable left ventricular assist device (LVAD) therapy has had
a remarkable evolution over the past 2 decades. Moving from a therapy once confined to …

Opinion statement The prevalence of patients living with advanced heart failure continues to
rise. For a subset of these patients, continuous-flow left ventricular assist devices (LVADs) …

Ventricular assist devices are commonly utilized in the treatment of end-stage heart failure.
Advances in continuous flow technology have improved efficiency, size, implantability …

Continuous-flow left ventricular assist devices (LVADs) have revolutionized advanced heart
failure care. These compact, fully implantable heart pumps are capable of providing …

Durable implantable left ventricular assist devices (LVADs) have been shown to improve
survival and quality of life for patients with stage D heart failure. Even though LVADs remain …

The field of durable left ventricular assist devices has advanced dramatically since its
introduction into the clinical realm. From the first-generation pulsatile HeartMate XVE device …

In the past decade, there has been tremendous growth in the use of durable mechanical
circulatory support (MCS) to treat patients with advanced heart failure and cardiogenic …

Continuous-flow left ventricular assist devices (LVAD) have emerged as the standard of care
for advanced heart failure patients requiring long-term mechanical circulatory support …